List view / Grid view
20 October 2025 | By
The balance between speed, scale, and compliance has never been more critical. As GLP-1s, biosimilars, and advanced therapies reshape global priorities, pharma leaders face a new question: how can manufacturing infrastructure evolve fast enough to keep pace?
17 October 2025 | By
Over 30 global pharma clients trust ROIS to deliver compliant, high-capacity manufacturing with precision and speed. As one of the top three CDMOs for injectables worldwide, we offer end-to-end, cross-format support. Our sites in the US and Europe all have dedicated NPI teams to ensure seamless tech transfer and rapid…
Gains US-based operations with its new Phoenix, Arizona injectable drug product manufacturing and packaging site.
In this article, Miguel Angel Ortega Sánchez of ROIS explores how the industry is adapting to new delivery formats, device bottlenecks, and strategic partnership models — and why flexibility, compliance, and tech transfer agility are now critical to success.
